Reine Allan 4
4 · Prime Medicine, Inc. · Filed May 22, 2025
Insider Transaction Report
Form 4
Reine Allan
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-05-21$1.18/sh+125,000$147,150→ 125,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.20, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each separate price within the range set forth in this footnote.